DOI:
10.1055/s-00000133
Gastroenterologie up2date
LinksClose Window
References
Johanson JF, Morton D, Geenen J. et al.
Multicenter, 4-week, double-blind, randomized, placebo-controlled trial of lubiprostone, a locally-acting type-2 chloride channel activator, in patients with chronic constipation.
Am J Gastroenterol 2008; 103: 170-177
We do not assume any responsibility for the contents of the web pages of other providers.